The role of lymph node dissection for clinical stage I malignant melanoma of intermediate thickness (1.51—3.99 mm)

Cancer

Volumn 56, Issue 2, 1985, Pages 413-418

  Elder, David E ^a   Guerry, Dupont ^a   Vanhorn, Marie ^a   Hurwitz, Shelley ^a   Zehngebot, Lee ^b   Goldman, Leonard I ^a   Larossa, Donato ^c   Hamilton, Ralph ^c   Bondi, Edward E ^a   Clark, Wallace H ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

^c LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGE; BLOOD AND HEMOPOIETIC SYSTEM; CLINICAL ARTICLE; HUMAN; LYMPH NODE DISSECTION; LYMPHATIC SYSTEM; LYMPHOCYTE; MELANOMA; MITOSIS RATE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; THERAPY; TUMOR VOLUME;

ACTUARIAL ANALYSIS; ADULT; AGE FACTORS; COMPUTERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS;

EID: 0021849610     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19850715)56:2<413::AID-CNCR2820560234>3.0.CO;2-T     Document Type: Article

References (28)

1. Malignant melanoma in southern Arizona
2. End results in the treatment of malignant melanoma: A study of 1190 cases
3. The influence of age, year of birth, and date of mortality from malignant melanoma in the population of England and Wales, Canada, and the white population of the United States
4. Chemotherapy of metastatic malignant melanoma
5. Optimal resection margin for cutaneous malignant melanoma
6. Low and high‐risk malignant melanoma: III. Prognostic significance of the resection margin
7. The surgical therapy of malignant melanoma
8. A multifactorial analysis of melanoma: II. Prognostic factors in patients with stage I (localized) melanoma
9. Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51–3.99 mm)
10. Efficacy of elective lymph node dissection in patients with intermediate thickness primary melanoma
11. Inefficacy of immediate node dissection in stage I melanoma of the limbs
12. Stage I melanoma of the limbs: Immediate versus delayed node dissection
13. A prospective randomised study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma
14. The surgical pathology of cutaneous malignant melanoma
15. Thickness, cross‐sectional areas and depth of invasion in the prognosis of cutaneous melanoma
16. Immunoperoxidase localization of lymphocyte subsets in the host response to melanoma and nevi
17. Prognostic factors for melanoma patients with lesions 0.76–1.69 mm in thickness
18. Nonparametric estimation from incomplete observations
19. A generalized Kruskal Wallis test for comparing K samples subject to unequal patterns of censorship
20. Regression model and life tables
21. The accuracy of predicting lymph node metastases in malignant melanoma by clinical examination and microstaging
22. Immunology and aging
23. A comparison of prognostic factors and surgical results in 1786 patients with localized (stage 1) melanoma treated in Alabama, USA and New South Wales, Australia
24. Selection of the optimum surgical treatment of stage I melanoma by depth of microinvasion
25. The lymph nodes: Form of treatment and results
26. Node dissection for extremity melanoma?